Raymond James Financial
BVS icon

Raymond James Financial’s Bioventus BVS Stock Holding History

Raymond James Financial’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,124
Closed -$107K – 5225
2025
Q2 		$107K Buy
16,124
+500
+3% +$3.55K ﹤0.01% 4841
2025
Q1 		$143K Sell
15,624
-708
-4% -$7.07K ﹤0.01% 4487
2024
Q4 		$171K Buy
+16,332
New +$193K ﹤0.01% 4437

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James Financial's BVS Position: Q3 2025 in Review

Raymond James Financial sold out of Bioventus (BVS) in Q3 2025, closing a stake of 16,124 shares — an estimated $107K sold.

Raymond James Financial first reported a position in BVS in Q4 2024 and held it in 3 quarters. The position peaked at $171K in Q4 2024. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.

  • Raymond James Financial reported no remaining Bioventus position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 16,124 Bioventus shares in Q3 2025, an estimated $107K.
  • Raymond James Financial first reported a position in Bioventus in Q4 2024 and held it in 3 quarters.
  • Raymond James Financial's Bioventus position peaked at $171K in Q4 2024.
  • 135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.